Access the full text.
Sign up today, get DeepDyve free for 14 days.
Diane Riby, Alessandro Mazzotta, D. Bergeat, L. Verdure, L. Sulpice, H. Bourien, A. Lièvre, Y. Rolland, E. Garin, K. Boudjema, J. Edeline (2020)
Downstaging with Radioembolization or Chemotherapy for Initially Unresectable Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology
R. Lewandowski, Kent Sato, Bassel Atassi, R. Ryu, A. Nemcek, L. Kulik, J. Geschwind, R. Murthy, W. Rilling, David Liu, L. Bester, J. Bilbao, A. Kennedy, R. Omary, R. Salem (2007)
Radioembolization with 90Y Microspheres: Angiographic and Technical ConsiderationsCardioVascular and Interventional Radiology, 30
Lu Wu, Lu Wu, D. Tsilimigras, A. Paredes, Rittal Mehta, J. Hyer, Katiuscha Merath, Kota Sahara, F. Bagante, E. Beal, F. Shen, T. Pawlik (2019)
Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall SurvivalWorld Journal of Surgery, 43
Y. Shaib, H. El‐Serag (2004)
The epidemiology of cholangiocarcinoma.Seminars in liver disease, 24 2
Shanshan Zou, Jiarui Li, Hua-bang Zhou, C. Frech, Xiaolan Jiang, Jeffrey Chu, Xinyin Zhao, Yuqiong Li, Qiaomei Li, Hui Wang, Jingyi Hu, Guanyi Kong, Mengchao Wu, Chuanfan Ding, Nansheng Chen, He-ping Hu (2014)
Mutational landscape of intrahepatic cholangiocarcinomaNature Communications, 5
R. Paz-Fumagalli, J. Core, C. Padula, S. Montazeri, J. McKinney, G. Frey, Z. Devcic, A. Lewis, C. Ritchie, K. Mody, S. Krishnan, B. Toskich (2021)
Safety and initial efficacy of ablative radioembolization for the treatment of unresectable intrahepatic cholangiocarcinomaOncotarget, 12
C. Mosconi, A. Gramenzi, S. Ascanio, A. Cappelli, M. Renzulli, C. Pettinato, G. Brandi, F. Monari, A. Cucchetti, F. Trevisani, R. Golfieri (2016)
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety studyBritish Journal of Cancer, 115
Donavan Cheng, Talia Mitchell, A. Zehir, Ronak Shah, R. Benayed, Aijazuddin Syed, Raghu Chandramohan, Zhen Liu, H. Won, Sasinya Scott, A. Brannon, Catherine O'Reilly, Justyna Sadowska, J. Casanova, Angela Yannes, J. Hechtman, Jinjuan Yao, Wei Song, D. Ross, Alifya Oultache, S. Dogan, L. Borsu, M. Hameed, K. Nafa, M. Arcila, M. Ladanyi, Mike Berger (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.The Journal of molecular diagnostics : JMD, 17 3
Jin Kim, H. Won, Y. Shin, P. Kim, Sung‐Gyu Lee, Shin Hwang (2011)
Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection.European journal of radiology, 80 3
Junxiao Wang, Yaoqin Xue, R. Liu, Zhenyu Wen, Zhenhu Ma, Xiang Yang, Lingxiang Yu, Bin Yang, Hui Xie (2023)
DEB-TACE with irinotecan versus C-TACE for unresectable intrahepatic cholangiocarcinoma: a prospective clinical studyFrontiers in Bioengineering and Biotechnology, 10
O. Ahmed, Q. Yu, A. Pillai, A. Liao, T. Baker (2022)
Abstract No. 303 ▪ FEATURED ABSTRACT Combination yttrium-90 radioembolization with concomitant systemic gemcitabine, cisplatin, and capecitabine as first-line therapy for intrahepatic cholangiocarcinoma (iCCA)Journal of Vascular and Interventional Radiology
J. Edeline, Y. Touchefeu, B. Guiu, O. Farge, D. Tougeron, I. Baumgaertner, A. Ayav, B. Campillo-Gimenez, L. Beuzit, M. Pracht, A. Lièvre, S. Sourd, K. Boudjema, Y. Rolland, E. Boucher, E. Garin (2020)
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.JAMA oncology
R. Salem, Siddharth Padia, M. Lam, J. Bell, C. Chiesa, K. Fowers, Bonnie Hamilton, J. Herman, S. Kappadath, T. Leung, L. Portelance, D. Sze, E. Garin (2019)
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working groupEuropean Journal of Nuclear Medicine and Molecular Imaging, 46
Jin Kim, H. Won, Y. Shin, Kyung-Ah Kim, P. Kim (2011)
Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma.AJR. American journal of roentgenology, 196 2
I. Konstantinidis, B. Koerkamp, R. Do, M. Gönen, Y. Fong, P. Allen, M. D'Angelica, T. Kingham, R. DeMatteo, D. Klimstra, N. Kemeny, W. Jarnagin (2016)
Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneCancer, 122
S. Buettner, A. Braat, G. Margonis, Daniel Brown, Kevin Taylor, A. Borgmann, S. Kappadath, A. Mahvash, J. Ijzermans, M. Weiss, A. Lamarca, Jon Bell, Juan Valle, J. Hagendoorn, B. Koerkamp, D. Sze, M. Lam (2020)
Yttrium-90 Radioembolization in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Analysis.Journal of vascular and interventional radiology : JVIR
O. Hyder, J. Marsh, R. Salem, E. Petre, S. Kalva, E. Liapi, D. Cosgrove, D. Neal, I. Kamel, A. Zhu, C. Sofocleous, J. Geschwind, T. Pawlik (2013)
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional AnalysisAnnals of Surgical Oncology, 20
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
Judith White, G. Carolan-Rees, M. Dale, H. Patrick, T. See, J. Bell, D. Manas, A. Crellin, N. Slevin, Ricky Sharma (2019)
Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.Journal of vascular and interventional radiology : JVIR
T. Helmberger, R. Golfieri, M. Pech, T. Pfammatter, D. Arnold, R. Cianni, G. Maleux, G. Munneke, O. Pellerin, B. Peynircioğlu, B. Sangro, N. Schaefer, N. Jong, J. Bilbao, Jean-Pierre Peters, J. Pelage, D. Manas, F. Kolligs, S. Ezziddin, R. Peters, Thomas Fis, T. Albrecht, O. D'archambeau, T. Ballı, S. Bilgiç, A. Bloom, R. Cioni, R. Fischbach, P. Flamen, L. Gérard, G. Grözinger, M. Katoh, M. Koehler, J. Kröger, C. Kuhl, F. Orsi, M. Ozgun, P. Reimer, M. Ronot, A. Schmid, A. Vit (2020)
Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)Cardiovascular and Interventional Radiology, 44
J. Banales, J. Marin, A. Lamarca, P. Rodrigues, Shahid Khan, L. Roberts, V. Cardinale, G. Carpino, J. Andersen, C. Braconi, D. Calvisi, M. Perugorria, L. Fabris, L. Boulter, R. Macías, E. Gaudio, D. Alvaro, S. Gradilone, M. Strazzabosco, M. Marzioni, C. Coulouarn, L. Fouassier, C. Raggi, P. Invernizzi, J. Mertens, A. Moncsek, Sumera Rizvi, J. Heimbach, B. Koerkamp, J. Bruix, A. Forner, J. Bridgewater, J. Valle, G. Gores (2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature Reviews. Gastroenterology & Hepatology, 17
O. Ahmed, Qian Yu, Mikin Patel, G. Hwang, A. Pillai, C. Liao, John Fung, Talia Baker (2022)
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as First Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma.Journal of vascular and interventional radiology : JVIR
T. Boerner, E. Drill, L. Pak, Bastien Nguyen, C. Sigel, A. Doussot, P. Shin, D. Goldman, M. Gonen, P. Allen, V. Balachandran, A. Cercek, J. Harding, D. Solit, N. Schultz, Ritika Kundra, H. Walch, M. D'Angelica, R. DeMatteo, J. Drebin, N. Kemeny, T. Kingham, Amber Simpson, J. Hechtman, E. Vakiani, M. Lowery, J. Ijzermans, S. Buettner, B. Koerkamp, M. Doukas, R. Chandwani, W. Jarnagin (2021)
Genetic Determinants of Outcome in Intrahepatic CholangiocarcinomaHepatology, 74
M. Köhler, F. Harders, F. Lohöfer, P. Paprottka, B. Schaarschmidt, J. Theysohn, K. Herrmann, W. Heindel, H. Schmidt, A. Pascher, L. Stegger, K. Rahbar, M. Wildgruber (2019)
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 RadioembolizationJournal of Clinical Medicine, 9
A. Smart, L. Goyal, N. Horick, N. Petkovska, A. Zhu, C. Ferrone, K. Tanabe, Jill Allen, L. Drapek, M. Qadan, Janet Murphy, C. Eyler, D. Ryan, T. Hong, J. Wo (2019)
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology, 27
Versione, Francesco Grossi (2020)
Common Terminology Criteria for Adverse EventsDefinitions
Aakash Gupta, A. Gordon, A. Gabr, A. Kalyan, S. Kircher, D. Mahalingam, M. Mulcahy, R. Merkow, A. Yang, D. Bentrem, J. Caicedo-Ramirez, A. Riaz, B. Thornburg, K. Desai, Kent Sato, E. Hohlastos, L. Kulik, A. Benson, R. Salem, R. Lewandowski (2022)
Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient CohortCardioVascular and Interventional Radiology, 45
H. Park, S. Yun, E. Lee, Seung Lee, Sung-Sik Han, S. Kim, Sang-Jae Park (2016)
Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After SurgeryAnnals of Surgical Oncology, 23
R. Salem, Kenneth Thurston (2006)
Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction.Journal of vascular and interventional radiology : JVIR, 17 10
D. Schartz, M. Porter, E. Schartz, J. Kallas, Akshya Gupta, D. Butani, A. Cantos (2022)
Transarterial yrittrium-90 radioembolization for unresectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.Journal of vascular and interventional radiology : JVIR
Taylor Robinson, L. Du, L. Matsuoka, D. Sze, A. Kennedy, R. Gandhi, B. Kouri, Z. Collins, N. Kokabi, C. Grilli, E. Wang, Justin Lee, Daniel Brown (2022)
Survival and Toxicities after Yttrium-90 Transarterial Radioembolization of Cholangiocarcinoma in the RESiN Registry.Journal of vascular and interventional radiology : JVIR
I. Bargellini, C. Mosconi, G. Pizzi, G. Lorenzoni, C. Vivaldi, A. Cappelli, G. Vallati, G. Boni, F. Cappelli, A. Paladini, R. Sciuto, G. Masi, R. Golfieri, R. Cioni (2020)
Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective StudyCardioVascular and Interventional Radiology
PurposeTransarterial radioembolization (TARE) is a liver-directed treatment for unresectable intrahepatic cholangiocarcinoma (ICC). The aim of this study is to evaluate factors affecting outcomes of TARE in heavily pretreated ICC patients.MethodsWe evaluated pretreated ICC patients who received TARE from January 2013 to December 2021. Prior treatments included systemic therapy, hepatic resection, and liver-directed therapies, including hepatic arterial infusion chemotherapy, external beam radiation, transarterial embolization, and thermal ablation. Patients were classified based on history of hepatic resection and genomic status based on next-generation sequencing (NGS). The primary endpoint was overall survival (OS) after TARE.ResultsFourteen patients with median age 66.1 years (range, 52.4–87.5), 11 females and 3 males, were included. Prior therapies included systemic in 13/14 patients (93%), liver resection in 6/14 (43%), and liver-directed therapy in 6/14 (43%). Median OS was 11.9 months (range, 2.8–81.0). Resected patients had significantly longer median OS compared to unresected patients (16.6 versus 7.9 months; p = 0.038). Prior liver-directed therapy (p = 0.043), largest tumor diameter > 4 cm (p = 0.014), and > 2 hepatic segments involvement (p = 0.001) were associated with worse OS. Nine patients underwent NGS; 3/9 (33.3%) and had a high-risk gene signature (HRGS), defined as alterations in TP53, KRAS, or CDKN2A. Patients with a HRGS had worse median OS (10.0 versus 17.8 months; p = 0.024).ConclusionsTARE may be used as salvage therapy in heavily treated ICC patients. Presence of a HRGS may predict worse OS after TARE. Further investigation with more patients is recommended to validate these results.Graphical abstract[graphic not available: see fulltext]
Abdominal Radiology – Springer Journals
Published: Jul 1, 2023
Keywords: Intrahepatic cholangiocarcinoma; Radioembolization; Interventional oncology; Next generation sequencing; NGS
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.